Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia

Jonne Lintunen(University of Eastern Finland), Heidi Taipale(Niuvanniemi Hospital), Antti Tanskanen(University of Eastern Finland), Jari Tiihonen(Niuvanniemi Hospital), Markku Lähteenvuo(University of Eastern Finland)

Schizophrenia

January 21, 2021

10.1038/s41537-020-00135-y

Cited by 43

Related Papers

Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors

|World Psychiatry|2022|624

Vascular Endothelial Growth Factor-B Induces Myocardium-Specific Angiogenesis and Arteriogenesis via Vascular Endothelial Growth Factor Receptor-1– and Neuropilin Receptor-1–Dependent Mechanisms

|Circulation|2009|195

Growth Factor Therapy and Autologous Lymph Node Transfer in Lymphedema

|Circulation|2011|181

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder

|JAMA Psychiatry|2018|147

Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations

|Drugs|2021|147